Biogen CEO Michel Vounatsos told CNBC that the list price of $56,000 per year for the company's FDA-approved Alzheimer's disease drug aducanumab is "fair."
The U.S. is reporting an average of about 14,500 daily infections over the past week, as average daily cases have held below 15,000 for three days straight.
Some of the biggest names in the music industry have called on the U.K. government to change the way musicians get paid when their songs are streamed online.
The president's $4 trillion spending proposal would be positive for the U.S., even if it hikes up interest rates, Treasury Secretary Janet Yellen said.
Amazon has big health care ambitions, yet the CEO of virtual medicine Teladoc, which has seen its booming share price halved, isn't worried. Should he be?
Working remotely has brought more emails, chat messages and meetings. They have led to more software sounds, which isn't getting drowning out by office noise.
Get complete CNBC business news coverage online. Find the latest regional business news pertaining to the United States of America including headlines & top stories available on the official CNBC site.